Table 1.

Baseline characteristics of patients

Baseline characteristic	Value (N = 187)
Age (years), median (range)	36.4 (18–64)
Gender, N (%)
Male	108 (57.7%)
Primary diagnosis, N (%)
Leukaemia	77 (41.2%)
Acute lymphoblastic leukaemia	19
Acute myeloid leukaemia	39
Chronic myeloid leukaemia	7
Myelodysplastic syndrome	12
Lymphoma	66 (35.3%)
Non-Hodgkin lymphoma	24
Hodgkin lymphoma	42
Other malignancies	16 (8.5%)
Multiple myeloma	15
Germ-cell tumour	1
Non-malignancies	28 (14.9%)
Aplastic anaemia	14
Fanconi anaemia	1
Myelofibrosis	2
Red-cell aplasia	1
Sickle-cell anaemia	1
Thalassaemia	9
Type of transplant
Autologous	65 (34.8%)
Allogeneic	122 (65.2%)
Related donor	15
Unrelated donor	105
Haplo-identical transplant	2
Stem cell source, N (%)
Peripheral stem cells	166 (88.8%)
Bone marrow cells	19 (10.1%)
Bone marrow and peripheral stem cells	1 (0.5%)
Umbilical cord bank	1 (0.5%)
Conditioning regimen intensity, N (%)
Myeloablative	130 (69.5%)
Reduced intensity	55 (29.4%)
Reduced toxicity	1 (0.5%)
None	1 (0.5%)
Baseline comorbidity, N (%)
Cardiac disease	40 (21.4%)
Endocrine disease	25 (13.3%)
Kidney disease	10 (5.3%)
Liver disease	6 (3.2%)
Other	43 (22.9%)
GVHD, N (%)
Acute	16 (8.6%)
Chronic	31 (16.6%)
Both acute and chronic	38 (20.3%)
None	102 (54.5%)